Who Is Sean Bohen?
This article was originally published in Scrip
Executive Summary
Respected American scientist Sean Bohen made headlines Monday with news he will move to AstraZeneca PLC on September 15 from Genentech Inc., the biologics unit of Roche Holding AG where he has been senior vice president in charge of early clinical development. The California-based division, known in the jargon as gRED, has notched up a legendary string of cancer drug successes, and Bohen played a notable part in many of them.